Trade Pluri Inc. - PLUR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.2084 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.2958 |
| Open | 5.2458 |
| 1-Year Change | 598.79% |
| Day's Range | 5.2458 - 5.2958 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 5.5558 | 0.3100 | 5.91% | 5.2458 | 5.5558 | 5.2458 |
| Jul 24, 2024 | 5.3458 | 0.0500 | 0.94% | 5.2958 | 5.3458 | 5.2958 |
| Jul 23, 2024 | 5.5958 | 0.0000 | 0.00% | 5.5958 | 5.5958 | 5.5958 |
| Jul 22, 2024 | 5.3858 | -0.1600 | -2.89% | 5.5458 | 5.5458 | 5.3858 |
| Jul 16, 2024 | 5.7258 | 0.0000 | 0.00% | 5.7258 | 5.7458 | 5.7058 |
| Jul 15, 2024 | 5.5958 | -0.0100 | -0.18% | 5.6058 | 5.6058 | 5.5758 |
| Jul 12, 2024 | 5.6658 | 0.0300 | 0.53% | 5.6358 | 5.7358 | 5.6358 |
| Jul 11, 2024 | 5.5358 | -0.0500 | -0.90% | 5.5858 | 5.5858 | 5.4058 |
| Jul 10, 2024 | 5.5658 | 0.0000 | 0.00% | 5.5658 | 5.5758 | 5.5658 |
| Jul 9, 2024 | 5.5958 | 0.0400 | 0.72% | 5.5558 | 5.6458 | 5.5558 |
| Jul 8, 2024 | 5.7358 | 0.0000 | 0.00% | 5.7358 | 5.7358 | 5.7358 |
| Jul 5, 2024 | 5.9658 | 0.5200 | 9.55% | 5.4458 | 6.0658 | 5.4458 |
| Jul 3, 2024 | 5.5358 | 0.2400 | 4.53% | 5.2958 | 5.5758 | 5.2958 |
| Jul 2, 2024 | 5.2858 | 0.0200 | 0.38% | 5.2658 | 5.2858 | 5.2658 |
| Jul 1, 2024 | 5.4458 | -0.1600 | -2.85% | 5.6058 | 5.6058 | 5.4458 |
| Jun 28, 2024 | 5.8058 | 0.3800 | 7.00% | 5.4258 | 5.8058 | 5.4258 |
| Jun 27, 2024 | 5.1758 | 0.0300 | 0.58% | 5.1458 | 5.1958 | 5.1258 |
| Jun 26, 2024 | 4.7458 | 0.0700 | 1.50% | 4.6758 | 4.7558 | 4.6658 |
| Jun 25, 2024 | 4.4858 | -0.2900 | -6.07% | 4.7758 | 4.7958 | 4.4858 |
| Jun 24, 2024 | 4.8558 | -0.0300 | -0.61% | 4.8858 | 4.8958 | 4.8058 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Pluri Inc. Company profile
About Pluristem Therapeutics Inc.
Pluristem Therapeutics Inc. is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. Its operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company's products include PLX-PAD and PLX R18. The Company's PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. The Company's PLX products are administered using a standard needle and syringe. The Company's PLX products are in clinical-stage development for multiple indications, such as cardiovascular, orthopedic, pulmonary and women's health diseases.
Financial summary
BRIEF: For the six months ended 31 December 2021, Pluristem Therapeutics Inc. revenues was not reported. Net loss increased 6% to $22.4M. Higher net loss reflects General and administrative expenses increase of 30% to $4.8M (expense), Stock-based Compensation in SGA increase of 9% to $4.6M (expense), Research & Development Expense decrease of 75% to $72K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.82 to -$0.70.
Equity composition
Common Stock $0.00001 Par, 01/13, 100M auth., 58,333,206 issd. Insiders control 11.74%. IPO: NA. 11/07,1-for-200 reverse stock split. 11/07, Name changed from Pluristem Life Systems, Inc. 12/07, Exchanged changed from OTC Bulletin Board to NASDAQ.
| Industry: | Biotechnology & Medical Research (NEC) |
Matam Park Building 5
HAIFA
3508409
IL
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com